start portlet menu bar end portlet menu bar

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Home Conoscenze Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

The aim of this study was to assess the efficacy of a two shots M. hyo vaccine in a commercial pig farm in China, where two different vaccination protocols were used. 

Scarica articolo

932 KB

Informazioni sull'articolo

Pubblicato in

IPVS Congress China, 2018

Data

13 lug 2018

Autori

Huibo, N.; Guochun, W.; Wenyuan X.; Ming, H.W.; Martínez, C.

Riepilogo

This study shows that the recomended program of a double dose of MYPRAVAC® SUIS compared with the single dose protocol exhibits better growth performace, higher survival rate, better average daily gain and a lower Feed Conversion Ratio.

Prodotti correlati

MYPRAVAC® SUIS

Pubblicazioni correlate

Mycoplasma hyopneumoniae infection dynamics in a farm in vaccinated and non-vaccinated pigs Longitudinal study of Mycoplasma hyopneumoniae infection in naturally infected pigs Evaluation of three ELISAs for detecting serum antibodies against Mycoplasma hyopneumoniae

Condividi

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Display portlet menu
end portlet menu bar

Vedi anche

Pubblicazioni

Efficacy of Suiseng® Diff/A vaccine and its associated use with Suiseng® Coli/C against C....

17-01-2022
Malattia sintesi

Pathogenesis of C. difficile

02-02-2022
Notizie

Ci siamo evoluti per essere più forti

23-06-2021